![]() |
Volumn 25, Issue 5, 2016, Pages 375-379
|
Spleen tyrosine kinase (SYK) is a potential target for the treatment of cutaneous lupus erythematosus patients
|
Author keywords
Cutaneous lupus erythematosus; Innate immunity; Kinase inhibition; Targeted therapy
|
Indexed keywords
NUCLEIC ACID;
PROTEIN KINASE SYK;
CYTOKINE;
SYK PROTEIN, HUMAN;
ADULT;
ARTICLE;
CONTROLLED STUDY;
ENZYME PHOSPHORYLATION;
GENE EXPRESSION;
HUMAN;
IMMUNOCOMPETENT CELL;
IMMUNOHISTOCHEMISTRY;
IN VITRO STUDY;
KERATINOCYTE;
NORMAL HUMAN;
PROTEIN EXPRESSION;
REGULATORY MECHANISM;
SKIN BIOPSY;
SKIN LUPUS ERYTHEMATOSUS;
TREATMENT OUTCOME;
UPREGULATION;
CASE CONTROL STUDY;
CELL CULTURE;
ENZYMOLOGY;
METABOLISM;
PHOSPHORYLATION;
CASE-CONTROL STUDIES;
CELLS, CULTURED;
CYTOKINES;
HUMANS;
LUPUS ERYTHEMATOSUS, CUTANEOUS;
PHOSPHORYLATION;
SYK KINASE;
|
EID: 84966600302
PISSN: 09066705
EISSN: 16000625
Source Type: Journal
DOI: 10.1111/exd.12986 Document Type: Article |
Times cited : (27)
|
References (19)
|